Non-Hodgkin's Lymphoma (NHL)

DBCOND0030854Hemic and Lymphatic DiseasesImmune System Diseases

Non-Hodgkin's Lymphoma (NHL) is the indication for 16 drugs in DrugBank. It is covered by 17 curated, structured indications.

Also known as
Non Hodgkin's Lymphoma · Non-Hodgkin Lymphoma · Non-Hodgkin's Lymphoma · NHL · Non-Hodgkin
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT024516ICD-10C85.9SNOMED CT1172592001MedDRA10025311UMLSC0024305

What you can answer from here — as of October 22, 2026

16Indicated drugsWith each drug's targets and mechanism
Listed above
17Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
1,419Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Non-Hodgkin's Lymphoma (NHL) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In